Cite

HARVARD Citation

    Lee, J. et al. (n.d.). 64P Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?. Annals of oncology. p. . [Online]. 
  
Back to record